What does Dr. Meynen Femke - Reumatoloog do?

Dr. Meynen Femke - Reumatoloog is a specialist medical practice in Diest. Private Limited, started on 18 July 2019, 1 establishment.

What is the address of Dr. Meynen Femke - Reumatoloog?

The registered office of Dr. Meynen Femke - Reumatoloog is located at Rothstraat 46, 3290 Diest.

Is Dr. Meynen Femke - Reumatoloog still active?

Yes. According to the CBE (30 October 2026) Dr. Meynen Femke - Reumatoloog is active, legal situation “Normale toestand”, started on 18 July 2019.

Is Dr. Meynen Femke - Reumatoloog registered on Peppol?

Yes, Dr. Meynen Femke - Reumatoloog is registered on the Peppol network with ID 0208:0730818388.

What is the enterprise number of Dr. Meynen Femke - Reumatoloog?

The enterprise number of Dr. Meynen Femke - Reumatoloog is BE0730818388.

When was Dr. Meynen Femke - Reumatoloog founded?

Dr. Meynen Femke - Reumatoloog was founded on 18 July 2019.

Is Dr. Meynen Femke - Reumatoloog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 July 2019; 5 annual accounts filed, latest fiscal year 2025.

How much profit did Dr. Meynen Femke - Reumatoloog make in 2025?

Dr. Meynen Femke - Reumatoloog posted a profit after taxes of € 141,998 in financial year 2025.

What is the revenue of Dr. Meynen Femke - Reumatoloog?

As a small company, Dr. Meynen Femke - Reumatoloog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 203,678.

Dr. Meynen Femke - Reumatoloog (Private Limited) - Diest

Dossier Dr. Meynen Femke - Reumatoloog, printed on 30 October 2026 from databakkes.be/en/0730818388/dr-meynen-femke-reumatoloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Meynen Femke - Reumatoloog from Diest, company number BE0730818388, closed financial year 2025 with a result of € 141,998 after tax. For that financial year Dr. Meynen Femke - Reumatoloog recorded a gross margin of € 203,678 and equity of € 186,484. Compared with financial year 2024, the result moved from € 189,348 to € 141,998. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What it is worth Healthy

€ 186,484

▼ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 141,998

▼ 25% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 169,597

▼ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 186,483.

People and assets in 2025

Vehicles and equipment

€ 193

▼ 98% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 61,255

▼ 12% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 125,276 Gross margin 2022: € 125,276 First fiscal year in the series	€ 163,920 Gross margin 2023: € 163,920 ▲ 31% vs 2022 (€ 125,276) Favourable step	€ 273,233 Gross margin 2024: € 273,233 ▲ 67% vs 2023 (€ 163,920) Favourable step	€ 203,678 Gross margin 2025: € 203,678 ▼ 25% vs 2024 (€ 273,233) Unfavourable step	▼ 25%
Profit after taxes	€ 83,922 Profit after taxes 2022: € 83,922 First fiscal year in the series	€ 115,201 Profit after taxes 2023: € 115,201 ▲ 37% vs 2022 (€ 83,922) Favourable step	€ 189,348 Profit after taxes 2024: € 189,348 ▲ 64% vs 2023 (€ 115,201) Favourable step	€ 141,998 Profit after taxes 2025: € 141,998 ▼ 25% vs 2024 (€ 189,348) Unfavourable step	▼ 25%
Equity	€ 205,270 Equity 2022: € 205,270 First fiscal year in the series	€ 153,804 Equity 2023: € 153,804 ▼ 25% vs 2022 (€ 205,270) Unfavourable step	€ 211,152 Equity 2024: € 211,152 ▲ 37% vs 2023 (€ 153,804) Favourable step	€ 186,484 Equity 2025: € 186,484 ▼ 12% vs 2024 (€ 211,152) Unfavourable step	▼ 12%
Total debts	€ 32,355 Total debts 2022: € 32,355 First fiscal year in the series	€ 70,369 Total debts 2023: € 70,369 ▲ 117% vs 2022 (€ 32,355) Unfavourable step	€ 133,032 Total debts 2024: € 133,032 ▲ 89% vs 2023 (€ 70,369) Unfavourable step	€ 81,926 Total debts 2025: € 81,926 ▼ 38% vs 2024 (€ 133,032) Favourable step	▼ 38%
Cash	€ 90,761 Cash 2022: € 90,761 First fiscal year in the series	€ 157,316 Cash 2023: € 157,316 ▲ 73% vs 2022 (€ 90,761) Favourable step	€ 251,663 Cash 2024: € 251,663 ▲ 60% vs 2023 (€ 157,316) Favourable step	€ 169,597 Cash 2025: € 169,597 ▼ 33% vs 2024 (€ 251,663) Unfavourable step	▼ 33%
Retained profit	€ 205,269 Retained profit 2022: € 205,269 First fiscal year in the series	€ 153,803 Retained profit 2023: € 153,803 ▼ 25% vs 2022 (€ 205,269) Unfavourable step	€ 211,151 Retained profit 2024: € 211,151 ▲ 37% vs 2023 (€ 153,803) Favourable step	€ 186,483 Retained profit 2025: € 186,483 ▼ 12% vs 2024 (€ 211,151) Unfavourable step	▼ 12%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 166,667 Dividend 2023: € 166,667 Unchanged (€ 0) Unchanged	€ 132,000 Dividend 2024: € 132,000 ▼ 21% vs 2023 (€ 166,667) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 132,000) Unchanged	▼ 100%
Bank debt	€ 21,981 Bank debt 2022: € 21,981 First fiscal year in the series	€ 10,558 Bank debt 2023: € 10,558 ▼ 52% vs 2022 (€ 21,981) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 10,558) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 237,625 Balance sheet total 2022: € 237,625 First fiscal year in the series	€ 224,173 Balance sheet total 2023: € 224,173 ▼ 6% vs 2022 (€ 237,625) Unchanged	€ 344,184 Balance sheet total 2024: € 344,184 ▲ 54% vs 2023 (€ 224,173) Unchanged	€ 268,409 Balance sheet total 2025: € 268,409 ▼ 22% vs 2024 (€ 344,184) Unchanged	▼ 22%

Key figures of Dr. Meynen Femke - Reumatoloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Meynen Femke - Reumatoloog?

What happened at Dr. Meynen Femke - Reumatoloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 7, 2026 New annual accounts for financial year 2025: profit of € 141,998 (▼ 25% vs 2024). Source: NBB ↗
Jul 18, 2019 New establishment in Diest. KBO
Jul 18, 2019 Start of the company according to the CBE. KBO

In short

From € 83,922 profit in 2022 to € 141,998 profit in 2025.

Paid € 170,685 in corporate taxes since 2022.

Best year ever: 2024, with € 189,348 profit.

Paid out € 298,667 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rothstraat 46

3290 Diest

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0730.818.388

VAT number

BE 0730.818.388

Registered office

Rothstraat 46, 3290 Diest

Names & denominations

Dr. Meynen Femke - Reumatoloog

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

18 July 2019

Peppol

Active · Active since 9 Mar 2026

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗